JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co Days Payable?

JW (Cayman) Therapeutics Co's average Accounts Payable for the six months ended in Dec. 2023 was $0.71 Mil. JW (Cayman) Therapeutics Co's Cost of Goods Sold for the six months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for JW (Cayman) Therapeutics Co's Days Payable or its related term are showing as below:

JWCTF' s Days Payable Range Over the Past 10 Years
Min: 21.86 Med: 23.51 Max: 28.85
Current: 24.71

During the past 6 years, JW (Cayman) Therapeutics Co's highest Days Payable was 28.85. The lowest was 21.86. And the median was 23.51.

JWCTF's Days Payable is ranked worse than
87.76% of 719 companies
in the Biotechnology industry
Industry Median: 147.29 vs JWCTF: 24.71

JW (Cayman) Therapeutics Co's Days Payable declined from Dec. 2022 (27.39) to Dec. 2023 (0.00). It may suggest that JW (Cayman) Therapeutics Co accelerated paying its suppliers.

JW (Cayman) Therapeutics Co Days Payable Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co Days Payable Chart

JW (Cayman) Therapeutics Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

28.91

21.86

23.57

JW (Cayman) Therapeutics Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial						58.95	17.23	27.39	31.12	-

Competitive Comparison of JW (Cayman) Therapeutics Co's Days Payable

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW (Cayman) Therapeutics Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's Days Payable distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's Days Payable falls into.

JW (Cayman) Therapeutics Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

JW (Cayman) Therapeutics Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.091	+	0.458)	/	2 )	/	11.994	*	365
=	0.7745					/	11.994	*	365
=	23.57

JW (Cayman) Therapeutics Co's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.953	+	0.458)	/	2 )	/	0	*	365 / 2
=	0.7055					/	0	*	365 / 2
=	N/A

JW (Cayman) Therapeutics Co Days Payable Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

02126:Hong Kong

Address

No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN

Website

https://www.jwtherapeutics.com

JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Headlines

No Headlines